All
RSSArticles
-
Internal Medicine Alert - Full February 15, 2014 Issue in PDF
-
Integrative Medicine Alert - Full February 2014 Issue in PDF
-
Critical Care Alert - Full February 2014 Issue in PDF
-
Adding to Survival ( Again): Cervix Cancer
Bevacizumab added to chemotherapy, particularly paclitaxel and cisplatin, was efficacious in all response outcomes (objective response, progression-free survival, and overall survival) without diminution in quality of life or unacceptable toxicity. -
Annual Mammography Screening: The Debate Continues
Although annual screening mammography did increase the detection rate of non-palpable tumors, it did not reduce mortality from breast cancer over 25 years of follow-up. -
Continuous Use of Non-androgenic OC Improves Endometriosis Pain and Endometrioma Reoccurrence
Compared to cyclic use, a drospirenone-containing oral contraceptive pill used in a continuous fashion after the removal of an endometrioma is associated with a reduction in dysmenorrhea, non-menstrual pelvic pain, and reoccurrence of endometrioma formation. -
OB/GYN Clinical Alert - Full April 2014 Issue in PDF
-
The 21/7 Combined OCP: Is It Time to Abandon This Formulation?
-
ED Management - Full April 1, 2014 Issue in PDF
-
Medical Ethics Advisor - Full March 2014 Issue in PDF